Strategic Wealth Partners, Ltd. Bristol Myers Squibb CO Transaction History

Strategic Wealth Partners, Ltd.

$947 Million
Q3 2024

A detailed history of Strategic Wealth Partners, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Strategic Wealth Partners, Ltd. holds 5,205 shares of BMY stock, worth $300,224. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,205

Previous 5,416 3.9%

Holding current value

$300,224

Previous $224,000 20.09%

% of portfolio

0.03%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$39.66 - $51.75 $8,368 - $10,919	-211 Reduced 3.9%	5,205 $269,000
Q2 2024 Oct 08, 2024	SELL	$40.25 - $52.99 $60,415 - $79,537	-1,501 Reduced 21.7%	5,416 $224,000
Q1 2024 May 20, 2024	SELL	$47.98 - $54.4 $46,732 - $52,985	-974 Reduced 12.34%	6,917 $375,000
Q4 2023 May 20, 2024	SELL	$48.48 - $57.85 $60,745 - $72,486	-1,253 Reduced 13.7%	7,891 $404,000
Q3 2023 May 20, 2024	BUY	$57.89 - $64.73 $58,295 - $65,183	1,007 Added 12.38%	9,144 $530,000
Q2 2023 May 20, 2024	SELL	$63.71 - $70.74 $5,287 - $5,871	-83 Reduced 1.01%	8,137 $520,000
Q1 2023 Apr 24, 2023	SELL	$65.71 - $74.53 $12,024 - $13,638	-183 Reduced 2.18%	8,220 $569,000
Q4 2022 Apr 24, 2023	BUY	$68.48 - $81.09 $14,723 - $17,434	215 Added 2.63%	8,403 $604,000
Q3 2022 Apr 24, 2023	BUY	$0.13 - $76.84 $39 - $23,436	305 Added 3.87%	8,188 $582,000
Q2 2022 Aug 22, 2022	SELL	$72.62 - $79.98 $4.25 Million - $4.68 Million	-58,492 Reduced 88.12%	7,883 $607,000
Q1 2022 May 19, 2022	SELL	$61.48 - $73.72 $323,200 - $387,546	-5,257 Reduced 7.34%	66,375 $4.85 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $2.48 Million - $2.9 Million	46,315 Added 182.94%	71,632 $4.47 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $331,884 - $388,759	5,609 Added 28.46%	25,317 $1.5 Million
Q2 2021 Aug 25, 2021	SELL	$61.91 - $67.42 $57,885 - $63,037	-935 Reduced 4.53%	19,708 $1.32 Million
Q1 2021 May 24, 2021	SELL	$59.34 - $66.74 $79,574 - $89,498	-1,341 Reduced 6.1%	20,643 $1.3 Million
Q4 2020 Feb 18, 2021	SELL	$57.74 - $65.43 $70,211 - $79,562	-1,216 Reduced 5.24%	21,984 $1.36 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $263,316 - $291,789	-4,585 Reduced 16.5%	23,200 $1.4 Million
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $167,694 - $196,051	3,059 Added 12.37%	27,785 $1.63 Million
Q4 2019 Jan 30, 2020	SELL	$49.21 - $64.19 $73,175 - $95,450	-1,487 Reduced 5.67%	24,726 $1.59 Million
Q3 2019 Oct 28, 2019	BUY	$42.77 - $50.71 $1.02 Million - $1.21 Million	23,880 Added 1023.57%	26,213 $101 Million
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $5,399 - $5,970	121 Added 5.47%	2,333 $105,000
Q3 2018 Dec 06, 2018	SELL	$55.19 - $62.25 $5,519 - $6,225	-100 Reduced 4.33%	2,212 $137,000
Q2 2018 Sep 04, 2018	SELL	$50.53 - $62.98 $41,788 - $52,084	-827 Reduced 26.35%	2,312 $128,000
Q1 2018 Jul 13, 2018	BUY	$59.92 - $68.98 $188,088 - $216,528	3,139 New	3,139 $199,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.

Account

Strategic Wealth Partners, Ltd. Bristol Myers Squibb CO Transaction History